ctrl K

Watchlist Price Alert

Ventyx Biosciences Inc. (VTYX)

NASDAQ: VTYX · Real-Time Price · USD

2.22

-0.32 (-12.60%)

At close: Jun 17, 2025, 10:46 AM

Ventyx Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	27.26M	51.58M	64.82M	70.79M	244K	309K
Short-Term Investments	190.06M	200.64M	253.12M	187.78M	n/a	n/a
Long-Term Investments	35.62M	n/a	38.67M	28.15M	n/a	n/a
Other Long-Term Assets	1.03M	1.08M	96K	60K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	12.3M	12.13M	12.75M	n/a	n/a	n/a
Total Current Assets	229.63M	264.35M	330.69M	263.02M	245K	349K
Property-Plant & Equipment	10.28M	12.27M	1.94M	254K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	46.94M	13.35M	40.71M	28.46M	n/a	n/a
Total Assets	276.56M	277.69M	371.4M	291.48M	245K	349K
Account Payables	3.13M	5.76M	6.43M	4.66M	1.1M	362K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.05M	n/a	412K	n/a	n/a	n/a
Other Current Liabilities	8.59M	n/a	4.89M	n/a	n/a	n/a
Total Current Liabilities	12.78M	22.27M	16.36M	12.28M	1.4M	631K
Long-Term Debt	n/a	n/a	n/a	n/a	12.65M	3.85M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	16.85M	n/a
Total Long-Term Liabilities	9.74M	11.51M	1.15M	n/a	29.5M	3.85M
Total Liabilities	22.52M	33.77M	17.5M	12.28M	30.9M	4.48M
Total Debt	10.79M	12.51M	1.56M	n/a	12.65M	3.85M
Common Stock	7K	6K	6K	5K	n/a	n/a
Retained Earnings	-554.31M	-419.19M	-226.22M	-117.8M	-32.5M	-4.33M
Comprehensive Income	157K	-50K	-1.12M	-58K	n/a	n/a
Shareholders Equity	254.04M	243.92M	-226.22M	-117.8M	-30.65M	-4.13M
Total Investments	225.68M	200.64M	291.79M	215.93M	n/a	n/a